13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-07-10 Event — SEC 0001213900-26-077181 →

Boxer Capital Management, LLC Q32 Bio Inc. QTTB

Stake: Shares: CUSIP: 746964105 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-07-31
DTC 3.77
3,000,835 shares short · +32.6% vs prior

Other 13D/G Filings on Q32 Bio Inc.

FiledFormFilerStakeShares
2026-07-20 SCHEDULE 13D/A ORBIMED ADVISORS LLC 4,127,987 view →
2026-06-04 SCHEDULE 13G BIOTECHNOLOGY VALUE FUND L P view →
2026-06-01 SCHEDULE 13D/A ORBIMED ADVISORS LLC 4,127,987 view →
2026-05-28 SCHEDULE 13D/A Atlas Venture Fund X, L.P. 3.60% 864,261 view →
2020-04-20 SC Flynn James E view →
2020-01-31 SC Flynn James E view →
2019-12-30 SC Flynn James E view →

Other Filings by Boxer Capital Management, LLC

FiledFormIssuerStakeShares
2024-11-18 SC iTeos Therapeutics, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →